|本期目录/Table of Contents|

[1]包针,木胡牙提,杨玉春,等.吸烟的非瓣膜性房颤患者的临床特性分析[J].国际心血管病杂志,2018,03:171-175.
 BAO Zhen,MUHUYATI,YANG Yuchun,et al.Analysis of the clinical characteristics of smoking patients with non-valvular atrial fibrillation[J].International Journal of Cardiovascular Disease,2018,03:171-175.
点击复制

吸烟的非瓣膜性房颤患者的临床特性分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年03期
页码:
171-175
栏目:
临床研究
出版日期:
2018-05-25

文章信息/Info

Title:
Analysis of the clinical characteristics of smoking patients with non-valvular atrial fibrillation
作者:
包针木胡牙提杨玉春刘志强何鹏义张雷巧丽番
830054 乌鲁木齐,新疆医科大学第一附属医院心脏中心综合心脏内科
Author(s):
BAO Zhen MUHUYATI YANG Yuchun LIU Zhiqiang HE Pengyi ZHANG Lei QIAO Lifan.
Department of Cardiology, First Affiliated Hospital of Xinjiang Medical University, Xinjiang 830054, China
关键词:
心房颤动 非阵发性 吸烟 危险因素
Keywords:
Atrial fibrillation Smoking Risk factors Non-paroxysmal
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2018.03.012
文献标识码:
-
摘要:
目的:探讨吸烟的非瓣膜性心房颤动(房颤)患者的临床特性及吸烟对房颤的影响。方法:入选2010年1月至2016年12月于新疆医科大学第一附属医院住院治疗的非瓣膜性房颤患者1 297例,根据是否有主动吸烟史将患者分为吸烟组(n=452)与不吸烟组(n=845),分析两组房颤患者的一般临床资料,比较不同吸烟指数下、不同房颤类型下患者的临床特点。采用logistic回归分析吸烟是否为非阵发性房颤的独立危险因素。结果:吸烟组患者平均年龄明显小于不吸烟组,男性比例、合并心肌病比例、体质量指
Abstract:
Objective:To investigate the clinical characteristics of smoking patients with non-valvular atrial fibrillation(AF)and the effect of smoking on atrial fibrillation.Methods:A total of 1 297 patients with non-valvular AF who were admitted to First Affiliate

参考文献/References

[1] Schnabel RB, Yin X, Gona P, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study[J]. Lancet, 2015, 386(9989):154-162.
[2] Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study[J]. Circulation, 2014, 129(8):837-847.
[3] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Carardiology/American Heart Association task force on practice guidelines and the heart rhythm society[J]. Circulation, 2014, 130(23):2071-2104.
[4] Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities(ARIC)study[J]. Circulation, 2011, 123(14):1501-1508.
[5] Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control[M]. Geneva: World Health Organization(in collaboration with the World Heart Federation and World Stroke Organization), 2011.
[6] Chamberlain AM, Agarwal SK, Folsom AR, et al. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities(ARIC)study[J]. Heart Rhythm, 2011, 8(8):1160-1166.
[7] Heeringa J, Kors JA, Hofman A, et al. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study[J]. Am Heart J, 2008, 156(6):1163-1169.
[8] Wolf PA, Benjamin EJ, Belanger AJ, et al. Secular trends in the prevalence of atrial fibrillation: the Framingham Study[J]. Am Heart J, 1996, 131(4):790-795.
[9] Goette A, Lendeckel U, Kuchenbecker A, et al. Cigarette smoking induces atrial fibrosis in humans via nicotine[J]. Heart, 2007, 93(9):1056-1063.
[10] Fröhlich M, Sund M, Löwel H, et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population(MONICA Augsburg Survey 1994/95)[J]. Eur Heart J, 2003, 24(14):1365-1372.
[11] Dixit S, Pletcher MJ, Vittinghoff E, et al. Secondhand smoke and atrial fibrillation: data from the Health eHeart Study[J]. Heart Rhythm, 2016, 13(1):3-9.
[12] Sánchez-Quintana D, López-Mínguez JR, Pizarro G, et al. Triggers and anatomical substrates in the Genesis and perpetuation of atrial fibrillation[J]. Curr Cardiol Rev, 2012, 8(4):310-326.
[13] Lip GY, Frison L, Halperin JL, et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort[J]. Stroke, 2010, 41(12):2731-2738.
[14] Albertsen IE, Rasmussen LH, Lane DA, et al. The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study[J]. Chest, 2014, 145(3):559-566.
[15] Tell GS, Grimm RH, Vellar OD, et al. The relationship of white cell count, platelet count, and hematocrit to cigarette smoking in adolescents: the Oslo Youth Study[J]. Circulation, 1985, 72(5):971-974.
[16] Albertsen IE, Overvad TF, Lip GY, et al. Smoking, atrial fibrillation, and ischemic stroke: a confluence of epidemics[J]. Curr Opin Cardiol, 2015, 30(5):512-517.
[17] Angoulvant D, Villejoubert O, Bejan-Angoulvant T, et al. Effect of active smoking on comparative efficacy of antithrombotic therapy in patients with atrial fibrillation: the Loire valley atrial fibrillation project[J]. Chest, 2015, 148(2):491-498.
[18] Zhu W, Yuan P, Shen Y, et al. Association of smoking with the risk of incident atrial fibrillation: a meta-analysis of prospective studies[J]. Int J Cardiol, 2016, 218:259-266.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81560062)
通信作者:木胡牙提,Email:muhuyati@163.com
更新日期/Last Update: 2018-06-01